Pricing Log in Create free account
Friday 6 November 2026 Export PRAX’s income statement to Excel — free account

Praxis Precision Medicines, Inc.

PRAX Healthcare Biotechnology

Praxis Precision Medicines, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $8.6 million, up 249.5% from fiscal 2023.

Revenue
+1,349.1%
EPS
+13.3%
Free cash flow
−43.5%

Quarter to June 2026, against a year earlier

275.31 12.72 +4.84%
Market cap
$7.3B
P/E
0.0×
Fwd P/E
−24.3×
Dividend yield
—
F-score
n/a
Altman Z
19.09
Beneish M
n/a
Dividend safety
n/a
Overview Business Profile
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Praxis Precision Medicines, Inc. (PRAX) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
10-Q Jun 30, 2026 P1I2: 17 added · 2 removed · 10 modified
P2I1A: no material changes, the filing says 		Share dilution
8-K Aug 6, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Jul 7, 2026 8.01 Other events
8-K Jun 29, 2026 4.01 Change in the certifying accountant; 9.01 Financial statements and exhibits Auditor change
8-K Jun 29, 2026 8.01 Other events
8-K Jun 22, 2026 8.01 Other events
8-K Jun 10, 2026 5.07 Submission of matters to a vote of security holders
8-K Jun 1, 2026 8.01 Other events
8-K May 7, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Mar 31, 2026
8-K Apr 14, 2026 8.01 Other events
8-K Apr 6, 2026 8.01 Other events
10-K Dec 31, 2025 1: 25 added · 8 removed · 68 modified
1A: 15 added · 15 removed · 165 modified
7: 22 added · 19 removed · 47 modified
8-K Feb 19, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K/A Feb 6, 2026 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits
8-K Jan 8, 2026 5.02 Departure or appointment of directors or officers Officer departure
8-K Jan 6, 2026 8.01 Other events; 9.01 Financial statements and exhibits
8-K Jan 6, 2026 2.02 Results of operations and financial condition
8-K Dec 29, 2025 8.01 Other events
8-K Dec 9, 2025 8.01 Other events
8-K Dec 4, 2025 8.01 Other events
10-Q Sep 30, 2025
8-K Nov 5, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Oct 20, 2025 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Oct 16, 2025 8.01 Other events; 9.01 Financial statements and exhibits
8-K Oct 16, 2025 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Sep 2, 2025 8.01 Other events; 9.01 Financial statements and exhibits
8-K Aug 4, 2025 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Jun 30, 2025
10-Q Mar 31, 2025
8-K May 2, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Dec 31, 2024
8-K Feb 28, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jan 12, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Sep 30, 2024
8-K Nov 6, 2024 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Jun 30, 2024
8-K Aug 13, 2024 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K May 13, 2024 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Mar 5, 2024 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Jan 4, 2024 2.02 Results of operations and financial condition; 3.02 Unregistered sales of equity securities; 8.01 Other events
8-K Nov 7, 2023 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.